C4X Discovery Holdings plc
LSE: C4XD.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Clive James Dix
- Employees
- 49
- Headquarters
- Manchester, United Kingdom
- IPO year
- 2014
- Market cap
- £30.3M
- Website
- https://www.c4xdiscovery.com
Loading C4XD…
Loading profile data…Frequently asked questions about C4XD
What does C4X Discovery Holdings plc (C4XD.L) do?
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules...
Where does C4XD.L trade?
C4X Discovery Holdings plc (C4XD.L) trades on the London Stock Exchange.
What sector is C4XD.L in?
C4X Discovery Holdings plc (C4XD.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of C4X Discovery Holdings plc?
Clive James Dix is the chief executive officer of C4X Discovery Holdings plc (C4XD.L).
Where is C4X Discovery Holdings plc headquartered?
C4X Discovery Holdings plc is headquartered in United Kingdom.
Does C4XD.L pay a dividend?
C4X Discovery Holdings plc (C4XD.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did C4XD.L go public?
C4X Discovery Holdings plc (C4XD.L) completed its initial public offering in 2014.